Design Spaces for analytical methods

TrAC - Trends in Analytical Chemistry

Volumn 42, Issue , 2013, Pages 157-167

  Rozet, E ^a   Lebrun, P ^a   Hubert, P ^a   Debrus, B ^b   Boulanger, B ^c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Arlenda sa   (Belgium)

Author keywords

Analytical method development; Design of Experiments; Design Space (DS); Desirability function; Mean response surface; Optimization; Probability map; Quality assurance; Quality by Design (QbD); Robustness

Indexed keywords

DESIGN OF EXPERIMENTS; OPTIMIZATION; QUALITY ASSURANCE; ROBUSTNESS (CONTROL SYSTEMS); SURFACE PROPERTIES;

ANALYTICAL METHOD; DESIGN SPACES; DESIRABILITY FUNCTION; PROBABILITY MAPS; QUALITY BY DESIGNS; RESPONSE SURFACE;

DESIGN;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; CONCEPTUAL FRAMEWORK; DESIGN SPACE; EXPERIMENTAL DESIGN; INFORMATION PROCESSING; KNOWLEDGE SPACE; PRIORITY JOURNAL; PROBABILITY; PROCESS OPTIMIZATION; QUALITY CONTROL; RESPONSE SURFACE METHOD; REVIEW; SCREENING TEST; STATISTICAL PARAMETERS; TIME; UNCERTAINTY;

EID: 84871522634     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2012.09.007     Document Type: Review

References (78)

1. US Food and Drug Administration (FDA), Department of Health and Human Services, Pharmaceutical Quality for the 21st Century A Risk-Based Approach Progress Report, May 2007. http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm128080.html.
2. US Food and Drug Administration (FDA), Guidance for industry PAT-A framework for innovative pharmaceutical manufacturing and quality assurance, FDA, Washington, DC, USA, 2004.
3. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q8 (R2): Pharmaceutical Development, ICH, Geneva, Switzerland, 2009.
4. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q9: Quality Risk Management, ICH, Geneva, Switzerland, 2005.
5. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q10: Pharmaceutical Quality System, ICH, Geneva, Switzerland, 2008.
6. Lionberger R.A., Lee S.L., Lee L., Raw A., Yu L.X. AAPS J. 2008, 10:268.
7. Lebrun P., Krier F., Mantanus J., Grohganz H., Yang M., Rozet E., Boulanger B., Evrard B., Rantanen J., Hubert Ph. Eur. J. Pharm. Biopharm. 2012, 80:226.
8. Wu H., White M., Khan M.A. Int. J. Pharm. 2011, 405:63.
9. De Beer T.R.M., Wiggenhorn M., Hawe A., Kasper J.C., Almeida A., Quinten T., Friess W., Winter G., Vervaet C., Remond J.P. Talanta 2011, 83:1623.
10. D. Am Ende, K.S. Bronk, J. Mustakis, G. O'Connor, C.L. Santa Maria, R. Nosal, T.J.N. Watson, J. Pharm. Innov. 2 (2007) 71.
11. Harms J., Wang X., Kim T., Yang X., Rathore A.S. Biotech. Progr. 2008, 24(24):655.
12. Baldinger A., Clerdent L., Rantanen J., Yang M., Grohganz H. Pharm. Dev. Technol. 2012, 17:389.
13. Garcia Munoz S., Dolph S., Ward H.W. Comput. Chem. Eng. 2010, 34:1098.
14. Huang J., Kaul G., Cai C., Chatlapalli R., Hernandez Abad P., Ghosh K., Nagi A. Int. J. Pharm. 2009, 382:23.
15. Adam S., Suzzi D., Radeke C., Khinast J.G. Eur. J. Pharm. Sci. 2011, 42:106.
16. Lipsanen T., Antikainen O., Raikkonen H., Airaksinen S., Yliruusi J. Int. J. Pharm. 2007, 345:101.
17. Verma S., Lan Y., Gokhale R., Burgess D.J. Int. J. Pharm. 2009, 377:185.
18. Huang J., Goolcharran C., Ghosh K. Eur. J. Pharm. Biopharm. 2011, 78:141.
19. Vogt F.G., Kord A.S. J. Pharm. Sci. 2011, 100:797.
20. Schweitzer M., Pohl M., Hanna-Brown M., Nethercote P., Borman P., Hansen G., Smith K., Larew J. Pharm. Tech. 2010, 34:52.
21. Ermer J. Eur. Pharm. Rev. 2011, 16:16.
22. P. Nethercote, P. Borman, T. Bennett, G. Martin, P. McGregor, Pharm. Manufact. April (2010) 37.
23. Borman P., Roberts J., Jones C., Hanna-Brown M., Szucs R., Bale S. Sep. Sci. 2010, 2:1.
24. Rozet E., Ziemons E., Marini R.D., Boulanger B., Hubert Ph. Anal. Chem. 2012, 84:106.
25. K. Ishikawa, What is Total Quality Control? The Japanese Way, Prentice-Hall, Englewood Cliffs, NJ, USA, 1985, pp. 63-64.
26. Zhou L., Socha J., Vogt F.G., Chen S., Kord A.S. Am. Pharm. Rev. 2010, 13:74.
27. Borman P.J., Nethercote P., Chatfield M.J., Thompson D., Truman K. Pharm. Technol. 2007, 31:142.
28. Stamatis D. Failure Modes and Effects Analysis 2003, Second Edition, ASQ Quality Press, Milwaukee, WI, USA, FMEA from Theory to Execution.
29. van Leeuwen J.F., Nauta M.J., de Kaste D., Odekerken-Rombouts Y.M.C.F., Oldenhof M.T., Vredenbregt M.J., Barends D.M. J. Pharm. Biomed. Anal. 2009, 50:1085.
30. Borman P.J., Chatfield M.J., Damjanov I., Jackson P. Anal. Chim. Acta 2011, 703:101.
31. Mantanus J., Ziemons E., Lebrun P., Rozet E., Klinkenberg R., Streel B., Evrard B., Hubert P. Talanta 2010, 80:1750.
32. Montgomery D.C. Introduction to Statistical Quality Control 2009, Wiley, Hoboken, NJ, USA, p. 52. Sixth Edition.
33. International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, ICH, Geneva, Switzerland, 2005.
34. Bouabidi A., Rozet E., Fillet M., Ziemons E., Chapuzet E., Mertens B., Klinkenberg R., Hubert P. J. Chromatogr., A 2010, 1217:3180.
35. Rozet E., Marini R.D., Ziemons E., Boulanger B., Hubert P. J. Pharm. Biomed. Anal. 2011, 55:848.
36. Y. Vander Heyden, M. Jimidar, E. Hund, N. Niemeijer, R. Peeters, J. Smeyers-Verbeke, D.L. Massart, J. Hoogmartens, J. Chromatogr., A 845 (1999) 145.
37. Peterson J.J., Yahyah M. Stat. Biopharm Res. 2009, 1:441.
38. Bouabidi A., Ziemons E., Marini R., Hubert C., Talbi M., Bouklouze A., Bourichi H., El Karbane M., Boulanger B., Hubert P., Rozet E. Anal. Chim. Acta 2012, 714:47.
39. Dewé W., Govaerts B., Boulanger B., Rozet E., Chiap P., Hubert P. Chemom. Intell. Lab. Syst. 2007, 85:262.
40. Schoenmakers P.J., Billet H.A.H., Tijssen R., DeGaan L. J. Chromatogr. 1978, 149:519.
41. Snyder L.R., Dolan J.W., Grant J.R. J. Chromatogr. 1979, 165:3.
42. Schellinger A.P., Carr P.W. J. Chromatogr., A 2005, 1077:110.
43. R. Cela, E.Y. Ordoñez, J.B. Quintana, R. Rodil, J. Chromatogr., A (2012) (DOI: 10.1016/j.chroma.2012.07.081).
44. Horváth C., Melander W., Molnár I. J. Chromatogr. 1976, 125:129.
45. Heron S., Tchapla A. J. Chromatogr., A 1991, 556:219.
46. Snyder L.R., Dolan J.W. Adv. Chromatogr. 1998, 38:115.
47. Jandera P. Adv. Chromatogr. 2004, 43:1.
48. Vander Heyden Y., Nijhuis A., Smeyers-Verbeke J., Vandeginste B.G.M., Massart D.L. J. Pharm. Biomed. Anal. 2001, 24:723.
49. Czitrom V. Am. Statist. 1999, 53:126.
50. D. Brynn Hibbert, J. Chromatogr., B (2012) (DOI: 10.1016/j.jchromb.2012.01.020).
51. Lundstedt T., Seifert E., Abramo L., Thelin B., Nystrom A., Pettersen J., Bergman R. Chemom. Intell. Lab. Syst. 1998, 42:3.
52. Dejaegher B., Vander Heyden Y. J. Chromatogr., A 2007, 1158:138.
53. Marini R.D., Hubert P., Rozet E., Vander Y. Heyden, E. Ziemons, B. Boulanger, A. Bouklouze, J. Crommen. J. Pharm. Biomed. Anal. 2007, 44:640.
54. Bezerra M.A., Santelli R.E., Oliveira E.P., Villar L.S., Escaleira L.A. Talanta 2008, 76:965.
55. Ferreira S.L.C., Bruns R.E., da Silva E.G.P., dos Santos W.N.L., Quintella C.M., David J.M., de Andrade J.B., Breitkreitz M.C., Fontes Jardim I.C.S., Neto B.B. J. Chromatogr., A 2007, 1158:2.
56. Box G.E.P., Behnken D.W. Technometrics 1960, 2:455.
57. Doehlert D.H. Appl. Statist. 1970, 19:231.
58. Atkinson A.C., Tobias R.D. J. Chromatogr., A 2008, 1177:1.
59. B. Debrus, P. Lebrun, J. Mbinze Kindenge, F. Lecomte, A. Ceccato, G. Caliaro, J. Mavar Tayey Mbay, B. Boulanger, R.D. Marini, E. Rozet, P. Hubert, J. Chromatogr., A 1218 (2011) 5205.
60. J.J. Peterson. http://www.pharmamanufacturing.com/articles/2010/097.html.
61. Harrington E. Ind. Qual. Control 1965, 21:494.
62. Derringer G., Suich R. J. Qual. Technol. 1980, 12:214.
63. Peterson J.J., Lief K. Stat. Biopharm. Res. 2010, 2:249.
64. Peterson J.J. J. Qual. Technol. 2004, 36:139.
65. Herrador M.A., Asuero A.G., Gonzalez A.G. Chemom. Intell. Lab. Syst. 2005, 79:115.
66. Davison C., Hinkley D.V. Bootstrap methods and their application 1997, Cambridge University Press, Cambridge, UK.
67. B. De Backer, B. Debrus, P. Lebrun, L. Theunis, N. Dubois, L. Decock, A. Verstraete, P. Hubert, C. Charlier, J. Chromatogr., B 877 (2009) 4115.
68. Nistor I., Cao M., Debrus B., Lebrun P., Lecomte F., Rozet E., Angenot L., Frederich M., Oprean R., Hubert P. J. Pharm. Biomed. Anal. 2011, 56:30.
69. Rafamantanan M.H., Debrus B., Raoelison G.E., Uverg-Ratsimamang S., Rozet E., Hubert P., Quetin-Leclercq J. J. Pharm. Biomed. Anal. 2012, 62:23.
70. Fekete S., Fekete J., Molnár I., Ganzler K. J. Chromatogr., A 2009, 1216:7816.
71. Molnár I., Rieger H.-J., Monks K.E. J. Chromatogr., A 2010, 1217:3193.
72. Monks K.E., Rieger H.-J., Molnár I. J. Pharm. Biomed. Anal. 2011, 56:874.
73. Molnar I., Monks K.E. Chromatographia 2011, 73:S5.
74. Monks K., Molnar I., Rieger H.-J., Bogati B., Szabo E. J. Chromatogr., A 2012, 1232:218.
75. Lebrun P., Govaerts B., Debrus B., Ceccato A., Caliaro G., Hubert P., Boulanger B. Chemom. Intell. Lab. Syst. 2008, 91:4.
76. Krier F., Brion M., Debrus B., Lebrun P., Driesen A., Ziemons E., Evrard B., Hubert P. J. Pharm. Biomed. Anal. 2011, 54:694.
77. Debrus B., Lebrun P., Ceccato A., Caliaro G., Rozet E., Nistor I., Oprean R., Rupérez F.J., Barbas C., Boulanger B., Hubert P. Anal. Chim. Acta 2011, 691:33.
78. Rajagopal R., del Castillo E. J. Oper. Res. Soc. 2007, 58:779.